Prev Close | 162.46 |
Day Low/High | 159.60 / 163.18 |
52 Wk Low/High | 109.22 / 179.79 |
Prev Close | 162.46 |
Day Low/High | 159.60 / 163.18 |
52 Wk Low/High | 109.22 / 179.79 |
Exchange | NYSE |
Shares Outstanding | 136.69B |
Market Cap | 22.21B |
P/E Ratio | 38.55 |
Div & Yield | N.A. (N.A) |
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
After the market close, we have a number of earnings reports coming at us, and one of my standard practices is to make a list as to which companies are reporting, and what's expected. This way, as the results hit the tape, I can perform a quick tria...
Each of these picks focuses on less-traditional markets, from billboards, casinos and data centers, to mortgage servicing rights, healthcare and life science facilities.
The outlook for REITs is positive heading into 2017, thanks to a growing economy. Having a real estate mogul in the White House could help the sector too.
Having a real estate mogul in the White House is not a bad thing for REITS in 2017, said Wilson Magee, portfolio manager for the Franklin Real Estate Fund.
Rising interest rates are a negative for REIT investors, but there are select names that could be stand outs, according to Mizuho.
The threat of higher rates ahead has kept REIT shares in check so far in 2015.
But be wary of earnings preannouncements.
We survived the Fed, but another earnings season is coming.
Going for growth amid industry challenge.
My panel discussion featuring these 2 multinational companies.
Qualcomm's core business -- mobile and connective chipsets -- is more fertile than ever
Tired of being outbid on every Manhattan apartment you are interested in buying? Well, things are looking up.
Alexandria Real Estate Equities is thoroughly outperforming the Dow Jones U.S. Real Estate Index because of the high percentage of investment-grade biotech and pharma tenants it houses its buildings.
Pure Play REIT has a growing dividend and is a catalyst for leading life science real estate innovation and research. TheStreet's Brad Thomas reports from New York.